Natasha Clinton, MSN, APRN, AOCNP, BCMAS
Articles by Natasha Clinton, MSN, APRN, AOCNP, BCMAS
Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies
ByKashyap Patel, MD,Hirangi Mukhi, BS,Anjana Patel, BSc,Dhwani Mehta, MS,Natasha Clinton, MSN, APRN, AOCNP, BCMAS,Ben Brown,Sara Rogers, PharmD,William Oh, MD,Prasanth Reddy, MD, MPH Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.
The Role of In-Office Next Generation Sequencing to Advance Precision Medicine in Community Oncology
ByKashyap Patel, MD,Natasha Clinton, MSN, APRN, AOCNP, BCMAS,Hirangi Mukhi, BS,Maharshi Patel, BS, MBA The goal of precision medicine is to advance medical and scientific discoveries to offer more tailored, precise, and accurate health interventions to maximize the health benefits for patients.
COVID-19 Presents an Opportunity for Precision Medicine to Play Expanded Role in Care
ByKashyap Patel, MD,Natasha Clinton, MSN, APRN, AOCNP, BCMAS,Hirangi Mukhi, BS,Maharshi Patel, BS, MBA "We recommend following an assessment for patients with cancer and treatment priority determination that would assist in the management of these patients."